• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model" [Int. J. Cardiol. 227 (2017) 467-473].

作者信息

Tenekecioglu Erhan, Torii Ryo, Bourantas Christos, Abdelghani Mohammad, Cavalcante Rafael, Sotomi Yohei, Crake Tom, Su Solomon, Santoso Teguh, Onuma Yoshinobu, Serruys Patrick W

机构信息

Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.

Department of Mechanical Engineering, University College London, London, United Kingdom.

出版信息

Int J Cardiol. 2017 May 15;235:206. doi: 10.1016/j.ijcard.2017.03.001. Epub 2017 Mar 9.

DOI:10.1016/j.ijcard.2017.03.001
PMID:28285798
Abstract
摘要

相似文献

1
Corrigendum to "Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model" [Int. J. Cardiol. 227 (2017) 467-473].《猪冠状动脉模型中Absorb生物可吸收血管支架血流动力学特性评估》的勘误 [《国际心脏病学杂志》227 (2017) 467 - 473]
Int J Cardiol. 2017 May 15;235:206. doi: 10.1016/j.ijcard.2017.03.001. Epub 2017 Mar 9.
2
Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model.在猪冠状动脉模型中评估Absorb生物可吸收血管支架的血流动力学特性。
Int J Cardiol. 2017 Jan 15;227:467-473. doi: 10.1016/j.ijcard.2016.11.005. Epub 2016 Nov 4.
3
Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges.在植入 Absorb 依维莫司洗脱生物可吸收血管支架和 Xience V 依维莫司洗脱金属支架 1 年和 2 年后的血管舒缩功能比较评估：来自血管内造影、离体评估以及支架/支架段和近端及远端边缘基因分析的体内观察结果。
JACC Cardiovasc Interv. 2016 Apr 11;9(7):728-41. doi: 10.1016/j.jcin.2015.12.018.
4
Corrigendum to "Prognostic Impact of Interleukin-1 Receptor Antagonist in Patients with documented Coronary Artery Disease" [Int. J. Cardiol. 257 (2018) 24-29].《白细胞介素-1受体拮抗剂对确诊冠心病患者的预后影响》的勘误 [《国际心脏病学杂志》257卷（2018年）第24 - 29页]
Int J Cardiol. 2018 Jun 15;261:239. doi: 10.1016/j.ijcard.2018.03.012. Epub 2018 Mar 21.
5
Corrigendum to "One-quarter standard-dose ticagrelor better than standard-dose clopidogrel in Chinese patients with stable coronary artery disease: A randomized, single-blind, crossover clinical study" [Int. J. Cardiol. 215 (2016) 209-213].《四分之一标准剂量替格瑞洛在稳定型冠状动脉疾病中国患者中优于标准剂量氯吡格雷：一项随机、单盲、交叉临床研究》的勘误 [《国际心脏病学杂志》215 (2016) 209 - 213]
Int J Cardiol. 2017 Jan 15;227:956. doi: 10.1016/j.ijcard.2016.11.216. Epub 2016 Nov 15.
6
Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials?用于治疗冠状动脉疾病的生物可吸收血管支架：我们从随机对照临床试验中学到了什么？
Coron Artery Dis. 2017 Jan;28(1):77-89. doi: 10.1097/MCA.0000000000000414.
7
Corrigendum to "Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials" [Int. J. Cardiol. (2017) 137-144].
Int J Cardiol. 2017 May 15;235:205. doi: 10.1016/j.ijcard.2017.03.021. Epub 2017 Mar 11.
8
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.ABSORB II 随机对照临床试验：比较 Absorb 依维莫司洗脱生物可吸收血管支架系统与 XIENCE 依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变所致缺血性心脏病患者的安全性、疗效和性能的临床评估：原理和研究设计。
Am Heart J. 2012 Nov;164(5):654-63. doi: 10.1016/j.ahj.2012.08.010.
9
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.依维莫司洗脱生物可吸收血管支架治疗糖尿病患者 1 年的临床结果：ABSORB 和 SPIRIT 试验的汇总分析。
JACC Cardiovasc Interv. 2014 May;7(5):482-93. doi: 10.1016/j.jcin.2014.01.155. Epub 2014 Apr 16.
10
Corrigendum to "Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP -India ACS Registry)" [Int. J. Cardiol. 248 (2017) 1-6].《急性冠状动脉综合征患者管理中的性别差异：HPIAR（印度惠普急性冠状动脉综合征登记研究）的一年结果》勘误 [《国际心脏病学杂志》248 (2017) 1 - 6]
Int J Cardiol. 2018 Feb 15;253:197. doi: 10.1016/j.ijcard.2017.11.013.